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Introduction: Cardiovascular system presents cortical modulation. Post-stroke outcome can
be highly inﬂuenced by autonomic nervous system disruption. Heart rate variability (HRV)
analysis is a simple non-invasive method to assess sympatho-vagal balance.
Objectives: The purpose of this study was to investigate cardiac autonomic activity in
ischemic stroke patients and to asses HRV nonlinear parameters beside linear ones.
Methods: We analyzed HRV parameters in 15 right and 15 left middle cerebral artery
ischemic stroke patients, in rest condition and during challenge (standing and deep breath-
ing). Data were compared with 15 age- and sex-matched healthy controls.
Results: There was an asymmetric response after autonomic stimulation tests depending on
the cortical lateralization in ischemic stroke patients. In resting state, left hemisphere stroke
patients presented enhanced parasympathetic control of the heart rate (higher values for
RMSSD, pNN50 and HF in normalized units). Right hemisphere ischemic stroke patients
displayed a reduced cardiac parasympathetic modulation during deep breathing test. Beside
time and frequency domain, using short-term ECG monitoring, cardiac parasympathetic
modulation can also be assessed by nonlinear parameter SD1, that presented strong positive
correlation with time and frequency domain parameters RMSSD, pNN50, HFnu, while DFA
a1 index presented negative correlation with the same indices and positive correlation with
the LFnu and LF/HF ratio, indicating a positive association with the sympatho-vagal balance.
Conclusions: Cardiac monitoring in clinical routine using HRV analysis in order to identify
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potential cardiovascular complications, especially in right hemisphere ischemic stroke
patients with sympathetic hyperactivation.
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Cardiac dysautonomia is a common complication of stroke [1–
3]. Post stroke autonomic nervous system dysregulation has
attracted signiﬁcant interest in the last couple of decades.
Many facts involved in short term evolution and prognostic
still need to be clariﬁed.
Cardiovascular system presents cortical modulation. Both
human studies and experimental data revealed that insular
cortex, anterior cingulate gyrus, hypothalamus and amygdala
may be involved in central autonomic nervous system
regulation [4–6]. Lesions at these levels might be held
responsible of cardiac arrhythmias. After acute cerebrovascu-
lar events arrhythmias and electrocardiographic abnormali-
ties are common, even in the absence of structural heart
disease, with a high incidence of dysautonomia [7].
Studies about heart–brain connections proposed the
concept of neurogenic cardiac disease, clinically and patho-
genically different from the actual cardiac disease [8–11].
Identifying high risk patients prone to develop neurogenic
cardiac complications, by better understanding dysautonomia
pathophysiology, and further implementation of adequate
prophylactic and therapeutic measures, may signiﬁcantly
reduce mortality rate in stroke patients. The inﬂuence of
stroke's hemispheric lateralization in cardiovascular auto-
nomic dysregulation [12] has been illustrated using modern
neuroimaging data, including positron emission tomography
and functional magnetic resonance imaging data [13].
An acute ischemic lesion involving the cortical network
controlling the activity of the autonomic nervous system may
imbalance autonomic responses at cardiac level and lead to an
increased risk of arrhythmia [14]. Insular cortex, a complex
structure supplied by the middle cerebral artery (MCA), was
often used as a model to illustrate the possible lateralization
impact on sympatho-vagal balance, depending on the hemi-
spheric localization of the stroke. It has been reported that
cardiosympathetic centers are located in the anterior, medial
and superior parts of the insula, while posterior insula and
inferior parietal lobe are responsible for inhibiting and
modulating the cardiosympathetic outﬂow of the other parts
of the insula [15]. Autonomic imbalance associating increased
sympathetic activity may be reﬂected in cardiovascular
impairment post insular stroke [1].
Among different variables assessing the autonomic re-
sponse, heart rate variability (HRV) quantiﬁes sympatho-vagal
modulation at sino-atrial level. It has been shown that a
reduction of HRV may be an indicator of general illness,
including acute stroke, and it correlates with enhanced
sympathetic or reduced vagal tone, which may predispose
to higher risk of arrhythmia [16,17] and increased risk of
sudden cardiac death. HRV might provide prognostic informa-
tion in ischemic stroke. Graff and collaborators [18] underlinedthe contribution of HRV in-depth analysis to stroke prognosis
and stated that while HRV assessed by linear methods may
provide long-term prognostic value, complex, non-linear
measures of HRV may rather assess the impact of the
neurological state on temporary patterns of heart rate post
stroke [18]. In the same line of evidence, it has been recently
shown that acute ischemic stroke patients had a signiﬁcant
reduced complexity of HRV. Early assessment of HRV by non-
linear methods can be a potential predictor of stroke-in-
evolution in newly admitted non- atrial ﬁbrillation ischemic
stroke patients [19].
In addition to linear parameters, nonlinear parameters of
HRV might be useful to identify patients prone to cardiac
arrhythmia, thus a prognostic marker of cardiac function.
The Poincaré plot is a visual representation of the
dependence between successive RR intervals, ﬁrst used as a
qualitative tool [20] by ﬁtting an ellipse to the shape of the
Poincaré plot in order to calculate HRV indices [21]. This
geometrical technique can be used to assess the dynamics of
HRV by a representation of the values of each pair of R–R
intervals into a simpliﬁed phase space, describing the
dynamics of a phenomenon that can recognize the hidden
correlation patterns of a time series signal [22,23]. Each pair of
successive elements in a time series (tachogram) is pictured
into a simpliﬁed Cartesian plane [24,25]. Series of these points
at successive times outline a trajectory. This describes the
system's evolution and therefore is commonly applied to
assess the dynamics of HRV. Using this technique, SD1 and
SD2 are the semi-axis of this ellipse. SD1 is related to the fast
beat-to-beat variability, while SD2 describes the longer-term
variability, SD1/SD2 showing the ratio of short-term to long-
term interval variation. This quantitative method of analysis is
based on the notion of different temporal effects of changes in
the vagal and sympathetic modulation of the HR on the
subsequent R–R intervals without a requirement for a
stationary quality of the data [22,24,26,27].
SD1 is considered a parasympathetic index of sinus node
control being a measure of rapid changes in R–R intervals,
because vagal effects on the sinus node are known to develop
faster than sympathetically mediated effects [28,29] and SD2 is
inﬂuenced by both parasympathetic and sympathetic tonus
[30].
Other useful parameter is approximate entropy (ApEn), a
measure of the disorder in the HR signal which quantiﬁes the
regularity and complexity of time series. Sample entropy
(SampEn) is a less biased measure derived from approximate
entropy [23,31], which quantiﬁes signal complexity robustly
within short time segments [32]. The name refers to the
applicability to time series data sampled from a continuous
process and the algorithm suggests ways to employ sample
statistics to evaluate the results [33]. It measures system
complexity and unpredictability [34] and is the negative
natural logarithm of the conditional probability that two
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point, where self-matches are not included in calculating the
probability. Thus a lower value of SampEn also indicates more
self-similarity in the time series [33].
Detrended ﬂuctuation analysis (DFA) is used to quantify the
fractal scaling properties of R–R interval [35] and has been
validated for time series data [36]. DFA calculates the root-
mean-square ﬂuctuation of integrated and detrended time
series, permits the detection of intrinsic self-similarity
embedded in a non-stationary time series, and also avoids
the spurious detection of apparent self-similarity [36]. The
scaling exponent, the self-similarity a parameter represents
the autocorrelation properties of the signal: <0.5 anti-
correlated signal, large and small values of the time series
are more likely to alternate; a = 0.5 corresponds to white noise,
an a greater than 0.5 and less than 1.0 indicates positive
autocorrelation in the signal such that a large inter-beat
interval is more likely to be followed by large interval and vice
versa. a = 1 represents 1/f noise; for a ≥ 1, correlations exist but
cease to be of a power-law form and a = 1.5 indicates Brownian
noise or random walk [37–40]. DFA plot is not strictly linear but
rather consisted of two distinct regions of different slopes,
there is a short range scaling exponent (a1) over periods of 4–11
beats (or 4–13), and a long-range exponent (a2), over longer
periods (larger than 11 beats) [36,37].
2. Aim
The aim of this research is to illustrate autonomic nervous
system dysregulation in ischemic MCA stroke patients.
3. Materials and methods
The study included 30 ischemic stroke patients, within 6
months post stroke and 15 age- and sex-matched healthy
controls, volunteers from community dwelling people, with no
previous history of cerebrovascular pathology. All the subjects
were divided into three groups. In the ﬁrst group there were 15
patients with right MCA ischemic stroke (8 men and 7 women),
59.7  10.3 years old, in the second group there were 15
patients with left MCA ischemic stroke (7 men and 8 women),
59.4  8.43 years old, and the control group was based on
healthy volunteers (8 men and 7 women), 59.33  7.28 years
old. Patients were recruited from neurological department and
all patients gave consent in accordance with ethical principles.
The study was carried out in accordance with the Helsinki
Declaration.
Inclusion criteria were as follows: age between 40 and 75
years old, right handed patients, clinical assessment sugges-
tive of stroke, evaluation in the ﬁrst 6 months after the acute
event, computed tomography (CT) or magnetic resonance
imaging (MRI) showing a single ischemic lesion within left or
right hemisphere (superﬁcial and/or profound MCA territory)
and cardiologic evaluation prior to stroke.
Exclusion criteria were: congestive heart failure, moderate-
to-severe valvular dysfunction, any cardiomyopathy, previous
acute myocardial infarction and left ventricular hypertrophy,
arrhythmia on current admission (including atrial ﬁbrillation),dementia, any major concurrent illness (including renal failure
and malignancies), diabetes mellitus or other metabolic
pathologies generating polyneuropathy, any medication in-
terfering with HR (beta-blockers), fever, hypoxia, alterations in
consciousness or any relevant hemodynamic compromise on
admission.
For the stroke group, the patients were under speciﬁc
medication for their associated cardiovascular co-morbidities,
including statins (in case of hypercholesterolemia), platelet
antiaggregants and antihypertensive drugs (in case of arterial
hypertension) in different associations, including angiotensin-
converting-enzyme inhibitors, thiazide-like diuretics, calcium
channel blockers or angiotensin receptor blockers, but not
beta-blockers which could inﬂuence the presented data. Even
though, a pharmacological implication of these drugs in the
immediate outcome of stroke patients is an interesting subject
per se, this was not the topic of the present work. The control
group was not using any medication.
Sympathetic and parasympathetic modulation of the HR
was assessed in MCA ischemic stroke patients by analyzing
HRV parameters in resting condition and during challenge,
using BIOPAC® Acquisition System. This is an integrated
hardware and software system used for collecting and
processing biologic signals. BIOPAC System converts biologic
parameters in numeric data. Interpretation was based on
AcqKnowledge software, version 3.9.1.6, that allows detecting,
measuring and automatic assays the registered signal. The
data was afterwards analyzed using Kubios HRV program,
version 2.2 (Biosignal Analysis and Medical Imaging Group,
University of Eastern Finland). This program assesses HRV in
time and frequency domain, calculating linear and non-linear
parameters, as exempliﬁed in Figs. 1 and 2.
HRV comprises numerous parameters. Standard deviation
of the HR, known as standard deviation of N–N interval
(normal-to-normal) – SDNN, meaning the square root of its
variance, reﬂects the inﬂuence of the parasympathetic and
sympathetic system on HR modulation [16,41]. pNN50 is a
parameter evaluating parasympathetic activity [16,41]. It
illustrates the proportion of differences in consecutive, so-
called normal-to-normal RR intervals on ECG that are longer
than 50 ms and reﬂects the percentage of such intervals in
comparison to the total number of analyzed intervals.
Similarly, the root of the mean squared differences of
successive NN intervals (RMSSD) reﬂects parasympathetic
activity. The coefﬁcient of variation and the RMSSD are the
most valuable time-domain parameters for routine evaluation
in resting state as they provide highly reproducible results and
are not inﬂuenced by mean resting HR.
We calculated frequency domain parameters that assign
bands of frequency and then count the number of NN intervals
that match each band: high frequency (HF) from 0.15 to 0.4 Hz,
low frequency (LF) from 0.04 to 0.15 Hz and the very low
frequency (VLF) from 0.0033 to 0.04 Hz. Despite controversy on
the concept [42–44], it is generally agreed that the high-
frequency (HF) component reﬂects parasympathetic outﬂow
to the heart [45–47]. However, the origin of the low-frequency
(LF) component is less certain. It has been hypothesized that LF
spectral power is a marker of cardiac sympathetic modulation
in humans [48] and assumed that LF has a dominant sympathetic
component [16,49,50]. A more complex mechanism beyond this
Fig. 1 – Linear and nonlinear parameters of the heart rate variability using Kubios HRV® 2.2 analysis. Enhanced sympathetic
control of the heart rate in resting state recording in a right hemisphere ischemic stroke patient.
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still under debate. Also, despite serious limitations, the LF/HF
ratio was presumed as a tool to assess cardiovascular
autonomic regulation, while increases in LF/HF were as-
sumed to reﬂect a shift to sympathetic enhanced tonus while
decreases in this index correspond to a parasympathetic
enhanced tonus. With or without adjustment for HF spectral
power, total power or respiration, LF spectral power seems to
provide an index not of cardiac sympathetic tone, but of
baroreﬂex function [51,52]. Manipulations and drugs that
change LF power or LF/HF ratio may do so, not by affecting
cardiac autonomic outﬂows directly, but by affecting modu-
lation of those outﬂows by baroreﬂexes [53].
Recent clinical and animal studies concluded that although
sympathetic nerve activity was not directly recorded, the LF
component of the HR power spectrum probably results from
an interaction of sympathetic and parasympathetic nervous
systems and, as such, does not accurately reﬂect changes in
the sympathetic activity [54–57].
The VLF spectral power depends on more complex
mechanisms, inﬂuenced by the thermoregulatory and renin-
angiotensin system, in this respect, we preferred to use the
normalized units for the LF and HF (LFnu, HFnu), that remove
the VLF from the estimation.
All stroke patients and control subjects were evaluated
using BIOPAC system. ECG recordings were performed at least
5 min in each subject in a 22 8C atmosphere, in resting state,after 20 min of supine position, in the absence of any anterior
physical effort. A minimum of 264 RR intervals for each
recording were analyzed. It was recommended for all subjects
to refrain from drinking alcohol and caffeine one day prior to
the recordings and to be quiet and calm during ECG
registration.
Autonomic function was also evaluated by ‘‘deep breathing
test’’, which assesses parasympathetic response, measures HR
changes after 6 deep breaths during 1minute and ‘‘standing
test’’ that measure HR changes during passive movement
from supine position to orthostatic position, evaluating
sympathetic response. Orthostatic hypotension was deﬁned
as a decrease in systolic blood pressure of 20 mmHg or a
decrease in diastolic blood pressure of 10 mmHg within three
minutes of standing when compared with blood pressure in
the supine position.
Beside time and frequency domain parameters, some
authors considered the following algorithm in order to analyze
R–R variation: (RRmax  RRmin)  100/RRmean, which is the
difference between the shortest and longest RR interval
registered during short-term ECG recordings, given as a
percentage of the mean of all maximal and minimal peaks.
RR interval variation responses at rest were considered
abnormal when less than 10% [15,58].
The linear indexes obtained from time and frequency
domain analysis (mean RR, mean HR, SDNN, RMSSD, pNN50,
LFnu, HFnu, LF/HF ratio) and the nonlinear parameters (SD1,
Fig. 2 – Linear and nonlinear parameters of the heart rate variability using Kubios HRV® 2.2 analysis. Enhanced
parasympathetic control of the heart rate in resting state recording in a left hemisphere ischemic stroke patient.
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Kubios HRV analysis software.
SD2 may represent a reliable tool on 24 h ECG recordings.
Since the ECG tracks in our study were not obtained on 24 h
recordings, we preferred to not include these results in our
conclusions. Relationships between linear and nonlinear
indexes were tested using speciﬁc correlation tests.
Data were analyzed using the SPSS version 22.0 (IBM
Corporation, Chicago, IL, USA). The results of the univariate
analysis were reported as mean  standard deviation for
continuous variables.
Having into consideration the small sample size, series
normalization is very difﬁcult. This was evaluated using
Kolmogorov–Smirnov test. Applied comparative tests were
speciﬁc to the characteristics of the analyzed series. In the case
of pretest analysis, the homogeneity of variance for the
studied parameters was analyzed using Levene test, this being
the mandatory condition for applying the ANOVA analysis. In
the case of nonhomogeneous series, the groups were
compared using Kruskal–Wallis. In order to identify differ-
ences in the three studied groups' parameters, we used post
hoc multiple comparison analysis tests. In the case of
homogenous series we applied Duncan Test because, when
compared to Newman–Keuls or Tukey, there are the lowest
chances of type I error results. When in the three groups there
were statistically signiﬁcant differences between the variance
of analyzed parameters, we used Dunnett's test.Total count and percent were reported for categorical
variables. Chi-square test (Maximum-Likelihood and Yates)
was performed for categorical variables. Correlations between
variables were determined using univariate analysis based on
the nonparametric test Spearman Rank test. The signiﬁcance
level ( p-value), which represents the maximum error proba-
bility, was considered to be 0.05 (5%); a conﬁdence interval of
95% shows that the decision is correct.
4. Results
80% of right MCA ischemic stroke patients were hypertensive
and 86.6% of left MCA ischemic stroke patients had hyperten-
sion as a vascular risk factor. We found orthostatic hypoten-
sion in 40% of patients with left hemisphere stroke,
signiﬁcantly elevated percentage when compared with right
hemisphere stroke patients ( p < 0.05).
Left hemisphere stroke patients presented enhanced
parasympathetic control of the HR, evidenced by higher
RMSSD and pNN50 values in resting state when compared
to right hemisphere stroke patients ( p < 0.05) (Table 1). Also, in
resting state, pNN50 values were lower in right hemisphere
stroke patients compared to controls ( p < 0.05) (Table 1).
Moreover, frequency domain parameters (HFnu) also showed
enhanced parasympathetic control of the HR in left MCA
infarction compared to right MCA infarction ( p < 0.05) and to
Table 1 – Heart rate variability parameters in resting state.
HRV parameters in
resting state
Group 1 – right
hemisphere
stroke (n = 15)
Group 2 – left
hemisphere
stroke (n = 15)
Control
group (n = 15)
Levene test
df = 2
Group 1 vs.
Group 2
Group 1 vs.
control
Group 2 vs.
control
p-Value
RR (ms) 874.4  108.4 782  92.3 797.9  85.7 0.546 0.0135 0.031 0.645
SDNN 47.1  19.8 66.7  46.8 65.5  34.1 0.290 0.152 0.154 0.926
Heart rate 74.8  9.7 74.3  7.5 69.8  6.9 0.422 0.884 0.112 0.124
RMSSD 37.7  22.4 81.7  64.1 65.3  34.3 0.100 0.010 0.087 0.304
pNN50 3.2  3.8 12.2  13.7 17.2  16.8 0.0003* 0.052 0.004 0.282
LFnu 67.1  12.5 32.4  15.7 57  8.7 0.010* 0.0001 0.032 0.0001
HFnu 32.7  12.4 66.1  15.3 42.6  8.4 0.016* 0.0001 0.040 0.0001
LF/HF 2.6  1.6 0.5  0.3 1.3  0.3 0.000* 0.0001 0.001 0.049
SD1 26.7  15.8 58.1  45.4 43.4  20.8 0.020* 0.005 0.013 0.018
SD2 58.7  24.2 70.1  51.9 71.2  41.3 0.253 0.442 0.426 0.936
ApEn 0.8  0.2 0.6  0.2 0.8  0.1 0.331 0.097 0.770 0.066
SampEn 1.1  0.3 0.8  0.5 0.9  0.4 0.280 0.224 0.704 0.359
DFA a1 1.1  0.3 0.5  0.2 0.9  0.2* 0.329 0.00006 0.023 0.003
DFA a2 0.9  0.2 0.8  0.3 0.5  0.2* 0.206 0.314 0.0004 0.005
Values are expressed as a mean  standard deviation.
p-value < 0.05 was considered to be statistically signiﬁcant; df – degrees of freedom.
* p-value < 0.05 for Levene test ! the Dunnett's test was used for comparison.
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The increased vagal inﬂuence on the HR in left hemisphere
stroke patients is also conﬁrmed by high SD1 levels in resting
state when compared to controls ( p < 0.05).
On the other hand, in patients with right MCA stroke we
found a higher sympathetic control of the HR, when compared
to left MCA strokes ( p < 0.05) and to controls ( p < 0.05),
according to time and frequency domain parameters, associ-
ating higher values for the nonlinear parameter DFA a1.
During deep breathing test, left hemisphere stroke patients
described more pronounced vagal inﬂuence on the HR
expressed by RMSSD and HFnu parameters compared to right
hemisphere stroke patients ( p < 0.05) and to control groupTable 2 – Heart rate variability parameters in deep breathing te
HRV parameters
in deep breathing
test
Group 1 – right
hemisphere
stroke (n = 15)
Group 2 – left
hemisphere
stroke (n = 15)
Contro
group (n =
RR (ms) 862.3  111.3 788.5  98.1 733.2  70
SDNN 69.3  24.9 93.8  62.6 34.9  22.
Heart rate 73.1  7.9 69.8  4.2 68.7  6.8
RMSSD 38.3  23.8 117.6  85.2 74.8  46.
pNN50 6.1  5.4 13.9  16.9 5.8  3.8 
LFnu 47.4  1 29.9  11.7 47.0  11.
HFnu 52.3  15.8 69.6  11.6 52.9  11.
LF/HF 1.1  0.7 0.5  0.2 1.1  0.5 
SD1 53.1  32.8 83.4  60.4 28.6  15.
SD2 79.3  24.6 100.8  68.2 46.8  24.
ApEn 0.6  0.1 0.5  0.1 0.7  0.2 
SampEn 0.8  0.4 0.7  0.4 1.0  0.5 
DFA a1 0.9  0.3 0.7  0.2 0.9  0.2 
DFA a2 0.9  0.2 0.9  0.3 0.7  0.4*
Values are expressed as a mean  standard deviation.
p-value < 0.05 was considered to be statistically signiﬁcant; df – degrees 
* p-value < 0.05 for Levene test ! the Dunnett's test was used for compa( p < 0.05), as shown in Table 2. LF/HF was lower in left
hemisphere stroke patients, according to the same results.
Nonlinear parameters SD1 also show higher values in left
hemisphere stroke patients compared to controls ( p < 0.05)
(Table 2).
During standing test we noticed a decreased parasympa-
thetic control of the HR in right MCA ischemic stroke patients
(lower pNN50, SDNN values) compared to controls ( p < 0.05).
The frequency-domain parameters (LFnu, HFnu) underline the
same results toward a more decreased parasympathetic
control of the HR in right MCA ischemic stroke patients vs.
controls. Nonlinear parameters showed difference between
right and left hemisphere stroke patients, as shown in Table 3.st.
l
 15)
Levene test
df = 2
Group 1 vs.
Group 2
Group 1 vs.
control
Group 2 vs.
control
p-Value
.7 0.141 0.036 0.0007 0.112
3 0.002* 0.104 0.024 0.0004
 0.011* 0.054 0.021 0.905
2 0.001* 0.001 0.086 0.045
0.00002* 0.103 0.998 0.106
1 0.291 0.001 0.996 0.002
2 0.317 0.001 0.992 0.002
0.005* 0.01 0.954 0.027
5 0.0004* 0.102 0.246 0.002
1 0.0009* 0.183 0.047 0.002
0.457 0.179 0.336 0.061
0.664 0.489 0.279 0.184
0.163 0.071 0.693 0.128
0.466 0.611 0.053 0.121
of freedom.
rison.
Table 3 – Heart rate variability parameters in standing test.
HRV parameters in
standing test
Group 1 – right
hemisphere
stroke (n = 15)
Group 2 – left
hemisphere
stroke (n = 15)
Control
group (n = 15)
Levene test
df = 2
Group 1 vs.
Group 2
Group 1 vs.
control
Group 2 vs.
control
p-Value
RR (ms) 823.0  99.2 767.7  106.0 759.3  80.1 0.259 0.114 0.085 0.808
SDNN 43.6  29.4 56.4  33.3 68.5  22.1 0.245 0.240 0.024 0.217
Heart rate 83.6  8.1 81.0  10.9 74.4  8.6 0.763 0.056 0.012 0.450
RMSSD 32.4  19.6 49.2  46.7 35.2  22.2 0.0002* 0.320 0.814 0.228
pNN50 3.4  3.6 5.7  9.9 10.1  8.1 0.211 0.402 0.024 0.119
LFnu 73.60  11.8 67.3  18.9 58.2  6.1 0.007* 0.201 0.003 0.067
HFnu 26.3  11.7 32.4  18.7 41.5  6.1 0.007* 0.403 0.007 0.153
LF/HF 4.0  3.4 2.7  1.9 2.3  0.7 0.015* 0.139 0.069 0.649
SD1 23.3  13.9 37.9  32.4 31.4  19.8 0.002* 0.099 0.323 0.442
SD2 93.0  30.1 67.2  39.3 57.9  34.2 0.584 0.044 0.009 0.457
ApEn 0.6  0.1 0.6  0.2 0.6  0.2 0.753 0.710 0.821 0.576
SampEn 0.6  0.2 0.7  0.4 0.8  0.5 0.016* 0.735 0.239 0.359
DFA a1 1.2  0.2 1.0  0.4 1.1  0.3 0.328 0.087 0.298 0.802
DFA a2 1.2  0.2 1.1  0.3 0.9  0.4 0.021* 0.892 0.063 0.159
Values are expressed as a mean  standard deviation.
p-value < 0.05 was considered to be statistically signiﬁcant; df – degrees of freedom.
* p-value < 0.05 for Levene test ! the Dunnett's test was used for comparison.
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very strong correlation between SD1 and SDNN (r = 0.9,
p < 0.05) and between SD1 and RMSSD (r = 0.9, p < 0.05)
(Table 4). We found a negative correlation between SD1 and
DFA a1 (r = 0.7, p < 0.05) (Table 4). SDNN presented a negative
correlation with DFA a1 (r = 0.6, p < 0.05) and with RMSSD
(r = 0.9, p < 0.05) (Table 4). DFA a1 presented a negative
correlation with HFnu (r = –0.5, p < 0.05) and a positiveTable 4 – Relationships between linear (SDNN, RMSSD, LFnu, H
ApEn, DFA a1 and DFA a2) in resting state.
Correlation coefﬁcients calculated
RMSSD LF/HF LF nu HF nu SD1 
Include condition: Group 1 – right hemisphere stroke
SDNN 0.908* 0.169 0.169 0.177 0.908*
RMSSD 0.344 0.341 0.352 0.995*
LF/HF 0.997* 0.999* 0.344
LF nu 0.995* 0.341
HF nu 0.352 
SD1 
SD2 
ApEn 
SampEn 
DFA a1 
Include condition: Group 2 – left hemisphere stroke
SDNN 0.667* 0.153 0.165 0.132 0.644*
RMSSD 0.408 0.398 0.411 0.996*
LF/HF 0.999* 0.997* 0.432
LF nu 0.995* 0.424
HF nu 0.435 
SD1 
SD2 
ApEn 
SampEn 
DFA a1 
* p-Value < 0.05 was considered to be statistically significant.correlation with LFnu (r = 0.6, p < 0.05) and LF/HF ratio
(r = 0.5, p < 0.05) (Table 4).
During deep breathing test we found interesting connec-
tions between SD1 and other nonlinear parameters, as it
follows: SampEn (r = 0.7, p < 0.05), DFAa1 (r = 0.4, p > 0.05)
and DFA a2 (r = 0.7, p < 0.05) (Table 5). Same as during resting
state, we deduced a very strong correlation between SD1 and
time domain parameters SDNN (r = 0.8, p < 0.05) and RMSSDFnu and LF/HF) and nonlinear indexes (SD1, SD2, SampEn,
 based on the Spearman Rank Order test
SD2 ApEn SampEn DFA a1 DFA a2
0.914* 0.238 0.371 0.611* 0.315
0.779* 0.247 0.484 0.769* 0.353
 0.006 0.024 0.341 0.596* 0.091
 0.003 0.035 0.330 0.601* 0.115
0.009 0.012 0.349 0.590* 0.075
0.779* 0.247 0.484 0.769* 0.353
0.188 0.328 0.406 0.300
0.524* 0.278 0.159
0.428 0.206
0.082
0.918* 0.571* 0.571* 0.003 0.179
0.561* 0.493 0.375 0.595* 0.515*
 0.253 0.218 0.326 0.726* 0.332
 0.271 0.233 0.343 0.731* 0.336
0.221 0.221 0.321 0.712* 0.315
0.526* 0.468 0.329 0.597* 0.524*
0.662* 0.706* 0.135 0.026
0.924* 0.044 0.100
0.053 0.059
0.562*
Table 5 – Relationships between linear (SDNN, RMSSD, LFnu, HFnu and LF/HF) and nonlinear indexes (SD1, SD2, SampEn,
ApEn, DFA a1 and DFA a2) in deep breathing test.
Correlation coefﬁcients calculated based on the Spearman Rank Order test
RMSSD LF/HF LF nu HF nu SD1 SD2 ApEn SampEn DFA a1 DFA a2
Include condition: Group 1 – right hemisphere stroke
SDNN 0.891* 0.300 0.300 0.300 0.891* 0.909* 0.171 0.726* 0.318 0.579*
RMSSD 0.432 0.432 0.432 0.996* 0.732* 0.403 0.759* 0.459 0.703*
LF/HF 0.993* 0.998* 0.432 0.009 0.162 0.462 0.679* 0.338
LF nu 0.997* 0.432 0.009 0.162 0.462 0.679* 0.338
HF nu 0.432 0.009 0.162 0.462 0.679* 0.338
SD1 0.732* 0.403 0.759* 0.459 0.703*
SD2 0.026 0.574* 0.132 0.385
ApEn 0.541* 0.379 0.362
SampEn 0.691* 0.535*
DFA a1 0.471
Include condition: Group 2 – left hemisphere stroke
SDNN 0.891* 0.059 0.084 0.091 0.891* 0.971* 0.019 0.318 0.037 0.318
RMSSD 0.138 0.021 0.028 0.994* 0.821* 0.031 0.256 0.271 0.388
LF/HF 0.646* 0.646* 0.138 0.024 0.144 0.341 0.074 0.568*
LF nu 0.999* 0.021 0.140 0.158 0.499* 0.259 0.313
HF nu 0.028 0.149 0.158 0.497* 0.295 0.318
SD1 0.821* 0.031 0.256 0.271 0.388
SD2 0.016 0.353 0.141 0.241
ApEn 0.542* 0.125 0.228
SampEn 0.135 0.153
DFA a1 0.001
* p-Value < 0.05 was considered to be statistically significant.
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lation with SDNN (r = 0.7, p < 0.05). DFA a1 presented
negative correlation with frequency domain parameter HFnu
(r = –0.6, p < 0.05) and positive strong correlation with LFnu
(r = 0.6, p < 0.05) and with LF/HF ratio (r = 0.6, p < 0.05) (Table 5).
During standing test, a sympathetic activation test, we found a
very strong correlation between SD1 and RMSSD (r = 0.9,
p < 0.05) and positive correlation between SD1 and SDNN
(r = 0.5, p < 0.05) (Table 6). DFA a1 presented negative correla-
tion with RMSSD (r = 0.6, p < 0.05) and with SD1 (r = 0.6,
p < 0.05) (Table 6).
In left hemisphere stroke patients, in resting state, we observed
very strong correlations between nonlinear parameters SD1
and SDNN (r = 0.6, p < 0.05), RMSSD (r = 0.9, p < 0.05) (Table 4).
Another nonlinear parameter, ApEn, presented negative
correlation with SDNN (r = 0.5, p < 0.05) and SampEn a
negative correlation with SDNN (r = 0.5, p < 0.05). DFA a1
presented negative correlation with RMSSD (r = 0.5, p < 0.05),
with frequency domain parameter HFnu (r = 0.7, p < 0.05) and
negative correlation with SD1 (r = 0.5, p < 0.05) (Table 4).
During deep breathing test, we found a very strong correlation
between SD1 and SDNN (r = 0.8, p < 0.05) and RMSSD (r = 0.9,
p < 0.05) (Table 5). During standing test, we found a strong
negative correlation between SD1 and DFA a1 (r = 0.7,
p < 0.05). SD1 correlate with time domain parameters SDNN
(r = 0.8, p < 0.05), RMSSD (r = 0.8, p < 0.05) (Table 6). Also
SampEn correlates negatively with SDNN (r = 0.5, p < 0.05)
and DFA a1 correlates negatively, as in the other tests, with a
parasympathetic marker RMSSD (r = 0.6, p < 0.05) (Table 6).
Using the algorithm described in Methods, we found in
right hemisphere stroke patients attenuated responses to
Ewing tests indicated by low HRV based on RR intervalvariation (resting state 5.4  2.2%, standing test 8.4  2.9% and
deep breathing test 8.1  3.1%, p < 0.05), thus suggesting a
predominant sympathetic control of the heart rate. In left
hemisphere stroke patients we observed a tendency for
intensiﬁed HRV responses after applied activation tests
(resting state 8.7  6.2%, standing test 7.3  4.1% and deep
breathing test 11.9  8.4%, p = 0.06). This data is in line with our
previous results using time and frequency domain parame-
ters, characterizing the asymmetrical involvement of the
autonomic nervous system in the central control of the HR.
This data needs further conﬁrmation on larger study groups.
5. Discussion
HRV represents a simple, non-invasive method to assess and
monitor the sympathovagal balance in dynamics in healthy
and pathological condition. In 1987, Kleiger [59] demonstrated
a possible role of HRV in predicting mortality after acute
myocardial infarction. Since then, HRV has been investigated
as a risk marker in cardiology, intensive care, neurology and
many other ﬁelds [60,61]. It was established that reduced HRV
is a predictor for general mortality [62] and anticipated the
development of a number of risk factors, such as hypertension
or obesity, and that lowering risk proﬁles is associated with
increased HRV [63]. The purpose of our research was to
underline the differentiated central control inﬂuence on the
autonomic HR modulation in right and left MCA ischemic
stroke patients. We considered in our analysis time domain
parameters attributed to the parasympathetic activity as
RMSSD and pNN50 and frequency domain parameters as HF
(a large accepted parasympathetic parameter) or LF, which has
Table 6 – Relationships between linear (SDNN, RMSSD, LFnu, HFnu and LF/HF) and nonlinear indexes (SD1, SD2, SampEn,
ApEn, DFA a1 and DFA a2) in standing test.
Correlation coefﬁcients calculated based on the Spearman Rank Order test
RMSSD LF/HF LF nu HF nu SD1 SD2 ApEn SampEn DFA a1 DFA a2
Include condition: Group 1 – right hemisphere stroke
SDNN 0.539* 0.325 0.325 0.325 0.539* 0.973* 0.303 0.371 0.299 0.102
RMSSD 0.400 0.400 0.400 0.995* 0.415 0.116 0.075 0.606* 0.418
LF/HF 0.991* 0.995* 0.400 0.321 0.024 0.034 0.403 0.153
LF nu 0.994* 0.400 0.321 0.024 0.034 0.403 0.153
HF nu 0.400 0.321 0.024 0.034 0.403 0.153
SD1 0.415 0.116 0.075 0.606* 0.418
SD2 0.290 0.389 0.209 0.079
ApEn 0.923* 0.046 0.062
SampEn 0.044 0.159
DFA a1 0.265
Include condition: Group 2 – left hemisphere stroke
SDNN 0.729* 0.211 0.082 0.077 0.862* 0.968* 0.296 0.537* 0.469 0.555*
RMSSD 0.247 0.365 0.364 0.867* 0.624* 0.026 0.132 0.695* 0.539*
LF/HF 0.867* 0.867* 0.330 0.197 0.440 0.403 0.406 0.029
LF nu 0.999* 0.188 0.068 0.191 0.162 0.288 0.206
HF nu 0.187 0.065 0.196 0.156 0.286 0.215
SD1 0.759* 0.177 0.330 0.771* 0.730*
SD2 0.309 0.562* 0.276 0.421
ApEn 0.759* 0.126 0.159
SampEn 0.185 0.162
DFA a1 0.691*
* p-Value < 0.05 was considered to be statistically significant.
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conclusion on the LF and LF/HF ratio values. The involvement
of nonlinear parameters is still debated, as they are not
routinely used to deﬁne sympatho-vagal balance. We searched
for a correlation between linear parameters and the non-linear
parameters of the HRV (e.g. SD1 that reﬂects the short-term
variability, DFA a1) in stroke patients in order to underline the
sympathetic overactivation associated to reduced variability
of the heart rate in a group of patients more prone to develop
cardiac complications. It is known that healthy physiological
systems have several parallel regulatory mechanisms that
increase stability, and that stability is associated with complex
patterns in time series like heart beats [64]. These systems are
organized in such a way that they display scale invariance [65]
and long-range order [66]. Pathologic states are deﬁned by a
breakdown of these two related fractal attributes. A conse-
quence of such reorganization is often a loss of fractal, multi-
scale complexity and the emergence of highly periodic (single-
scale) behavior. This approach may serve important implica-
tions for new approaches to early disease detection and
prognostic assessment [64–68].
There are currently no normative data universally assumed
for short-term measures of HRV [69]. Several recent studies on
HRV data [70,71] proposed such normative for short-term
recordings of HRV obtained in normally healthy individuals,
but discrepant values were identiﬁed. Age, ethnicity, habitual
physical activity and cardio-metabolic condition contributed
importantly to the variability of the results, even in large
cohorts [69]. Given the spectrum of physiopathological
conditions that generate approximate values for the HRV, its
role may principally serve to signal a general pattern of the
autonomic nervous system response in a given, temporaryphysiopathological context. As comprehensive investigations
of HRV indices in large diseased populations are still lacking, it
is difﬁcult to formulate pertinent clinical measures based on
HRV evaluation in neurovascular patients, and further
research needs to establish precise sets of values reﬂecting
autonomic response, pragmatically applicable in clinical
setups.
Stroke can induce cardiac autonomic imbalance, therefore
causing secondary cardiovascular complications. As sug-
gested by Ozdemir and Hachinski [12], awareness of a
‘‘neurogenic heart syndrome’’ and recognition of right
hemispheric involvement, especially the insular cortex, is
important [72]. The risk of developing cardiac arrhythmia
(atrial ﬁbrillation, ventricular tachyarrhythmia) or other ECG
modiﬁcations (prolonged QT, AV block, inversed T wave) in
post stroke patients is higher when associated to raised
sympathetic activity and low HRV. Several investigators have
reported decreased HRV in stroke patients, not only in the
acute phase, but also within the next six months [73–76].
Ampliﬁed by catecholaminergic storm, it may induce cardiac
ventricular arrhythmias or myocardial detriment, which is
often associated with sudden death [77,78]. Early cardiac
monitoring may change long-term prognosis, since sympa-
thetic overactivity predisposes to secondary cerebro- and
cardiovascular events. Therefore, it is highly important to
manage dysautonomic imbalance, cardiac causes being held
responsible for 2 up to 6% of total mortality three months after
acute ischemic stroke [79].
In our research, patients from the studied groups presented
cortical lateralization reﬂected by linear parameters (RMSSD,
pNN50, SDNN, HFnu, LFnu, LF/HF ratio): sympathetic activa-
tion reﬂected on the control of the HR in right hemisphere
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control of the HR in left MCA in ischemic stroke patients. SD1
could be considered as a reliable parameter for the parasym-
pathetic modulation in short-term (5 min) ECG recordings, as it
presented very strong correlations with parasympathetic time
domain parameters, both in resting state and during activation
tests.
We also observed a negative correlation of DFA a1
nonlinear parameter with SD1 and HFnu, and a positive
correlation with LFnu and LF/HF ratio, indicating a positive
association with the sympatho-vagal balance. We did not ﬁnd
consistent results regarding ApEn and SampEn nonlinear
parameters during resting state and activation tests.
These data are in line with other clinical studies, where
intraoperative electrical stimulation of the insula determined
cardiovascular activity changes in right handed patients,
which appear to be lateralized: left insular cortex stimulation
was correlated with bradycardia and arterial hypotension
(parasympathetic activation), while right insular cortex gen-
erated tachycardia and hypertension [80]. In epileptic patients
with drug refractory seizures who underwent intracarotid
amobarbital injections (wada test), it was noticed a sympa-
thetic tonus predominance in the right hemisphere and a
parasympathetic predominance and up regulation of barore-
ceptor sensitivity in the left hemisphere [81].
In rodents, when right posterior insular cortex ablation
determined increased heart rate and blood pressure [82] and
the occlusion of right MCA determined myocytolysis, in-
creased blood pressure and circulating norepinephrine levels,
especially when the insular cortex was involved [83].
Therefore, the left insular cortex appears to modulate the
vagal activity, reﬂected on the cardiac autonomic control by
bradycardia and increasing HRV [9], which is mediated by the
parasympathetic nervous system through the vagus nerve.
There are important results [84] that showed signiﬁcant
increases in total HRV and increased parasympathetic drive
(as revealed by time domain measures of HRV, i.e., an increase
in RMSSD) in subjects with bradycardia. Clinically, bradycardia
is likely to be cardioprotective in aging populations based upon
these HRV ﬁndings [84].
Using for the ﬁrst time continuous ECG monitoring in acute
ischemic stroke patients, Colivicchi et al. [72] noticed that right
insular cortex involvement associated signiﬁcantly lower
values of SDNN, of RMSSD and higher LF/HF ratio. This data
supports our ﬁndings that in right ischemic stroke patients
there is higher sympathetic tonus predominance on the HR
control. Cardiac dysfunction appears secondary to impaired
cerebral structures involved in central control, particularly the
insular cortex which is located in the vascular territory of the
MCA. Insular cortex was often used as a model to illustrate the
possible lateralization impact on sympatho-vagal balance,
depending on the hemispheric localization of the stroke.
Insular cortex has extended connections with different
autonomic centers and with the limbic system that is why
other studies showed reversed responses, possibly explained
by the predominance of the autonomic activity from the
controlateral, non-ischemic hemisphere [15].
These conﬂicting results regarding speciﬁc autonomic roles
of the central nervous system structures justify further studies
using functional brain imagery in stroke patients, in order tobetter understand a possible cortical lateralization and
eventually describe other cerebral structures involved in post
stroke cardiac dysautonomia patients. Overall, our data
suggest that there is a differential cerebral modulation of
autonomic function depending on the side of the brain.
There is a strong relationship among nonlinear indices SD1
and DFA a1 and linear parameters in ischemic stroke patients
in short term recordings, which could provide supplementary
conﬁrming data on the sympatho-vagal impaired modulation
at cardiac level, following an acute neurovascular lesion. As
proven by previous studies, early cardiac monitoring of the
stroke patients using HRV linear and nonlinear parameters in
order to identify a sympathetic overactivation on the control of
the heart rate, may improve the therapeutically approach and
impact the short-term prognostic.
Randomized trials are needed for conﬁrmation of the
beneﬁts of ACE inhibitors or beta-blockers to stabilize the
sympatho-vagal balance in patients prone to neurogenic heart
disease and fatal cardiac arrhythmia. The role of cardio-
deﬁbrillator in order to decrease mortality rate can be
discussed. Multiple clinical trials documented signiﬁcant
survival beneﬁts of implantable cardioverter deﬁbrillator in
certain subsets of patients (experiencing decreased left
ventricle ejection fraction secondary to cardiomyopathy,
sustained ventricular arrhythmias, etc.) with high risk of
sudden cardiac death [85,86]. However, progress in cardiac
monitoring protocols in stroke units, but also pragmatic
analysis of cost-effectiveness issues are still necessary to
determine the precise use of deﬁbrillator in patients with
documented ventricular dysrhythmias. Furthermore, animal
models in experimental studies showed that vagal nerve
stimulation and rehabilitative training enhanced the forelimb
recovery after ischemic stroke [87]. Preventing sympathetic
hyperactivity and secondary cardiac arrhythmia by rising
vagal activity could be achieved by transcranian magnetic
stimulation [88,89]. It still remains to be clariﬁed if vagal nerve
stimulation would be a possible preventive strategy for cardiac
arrhythmias in post-stroke patients.
Since clear guidelines outlining an approach for stroke
patients more prone to develop autonomic dysfunction are
still needed, this data points out potentially effective predic-
tive parameters to be used in clinical routine in stroke and
rehabilitation units to assess severe arrhythmic risk and
cerebral outcome. The presence and magnitude of autonomic
dysfunction, as shown by our results, may foster the
elaboration of prognostic scores, necessary for a global
approach of neurological patients at risk.
One limitation of our study is the low number of
participants which may decrease the statistical power.
Therefore, further studies with larger groups are needed in
order to conﬁrm and strengthen these results.
6. Conclusions
Our results indicate that the autonomic nervous system
disposes asymmetric, lateralized responses to different stim-
ulation autonomic tests in stroke patients. Right hemisphere
stroke has a more pronounced sympathetic control on the HR
than left hemisphere in right handed patients.
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